Home/Filings/4/0001645842-21-000044
4//SEC Filing

Singh Enakshi 4

Accession 0001645842-21-000044

CIK 0001645842other

Filed

Dec 29, 7:00 PM ET

Accepted

Dec 30, 4:52 PM ET

Size

6.9 KB

Accession

0001645842-21-000044

Insider Transaction Report

Form 4
Period: 2021-12-28
Singh Enakshi
Chief Financial Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2021-12-28$1.70/sh+50,000$85,000227,000 total
  • Exercise/Conversion

    Stock Options

    2021-12-2850,0000 total
    Exercise: $1.70Exp: 2025-07-30Common Stock (50,000 underlying)
Footnotes (2)
  • [F1]The transaction by the Reporting Person is an exercise of an in-the-money option for cash consideration and does not involve the sale of any shares.
  • [F2]The shares subject to the Option are fully vested and immediately exercisable.

Issuer

Zymergen Inc.

CIK 0001645842

Entity typeother

Related Parties

1
  • filerCIK 0001846617

Filing Metadata

Form type
4
Filed
Dec 29, 7:00 PM ET
Accepted
Dec 30, 4:52 PM ET
Size
6.9 KB